{
    "nct_id": "NCT06072807",
    "official_title": "Brain [18F]-FES PET/CT in the Diagnosis, Treatment Planning and Response Assessment of Brain Metastases in Patients With Estrogen-Receptor Positive Breast Cancer",
    "inclusion_criteria": "1. Active diagnosis of ER+ breast cancer (biopsy proven) and new or recurrent brain metastases (biopsy proven or suspected based on MRI appearance)\n2. Ability to provide informed consent\n3. Discontinuation of ER modulators for at least 8 weeks, and discontinuation of ER down regulators for at least 28 weeks (as per manufacturer guidelines)\n4. Age >=18 years\n5. Eastern Cooperative Oncology Group performance score 0-1\n6. Life expectancy >=6 months\n7. Planned for radiation treatment for brain metastases\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Pregnancy\n2. Unable to undergo Standard of Care\n3. Allergy to FES.",
    "miscellaneous_criteria": ""
}